These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28614410)

  • 1. Model-based optimization approaches for precision medicine: A case study in presynaptic dopamine overactivity.
    Hsu KC; Wang FS
    PLoS One; 2017; 12(6):e0179575. PubMed ID: 28614410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fuzzy Decision Making Approach to Identify Optimum Enzyme Targets and Drug Dosage for Remedying Presynaptic Dopamine Deficiency.
    Hsu KC; Wang FS
    PLoS One; 2016; 11(10):e0164589. PubMed ID: 27736960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 4. Leveraging big data to transform target selection and drug discovery.
    Chen B; Butte AJ
    Clin Pharmacol Ther; 2016 Mar; 99(3):285-97. PubMed ID: 26659699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical proteomics-driven precision medicine for targeted cancer therapy: current overview and future perspectives.
    Zhou L; Wang K; Li Q; Nice EC; Zhang H; Huang C
    Expert Rev Proteomics; 2016; 13(4):367-81. PubMed ID: 26923776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated Detection of Cancer Associated Genes Using a Combined Fuzzy-Rough-Set-Based F-Information and Water Swirl Algorithm of Human Gene Expression Data.
    Ganesh Kumar P; Kavitha MS; Ahn BC
    PLoS One; 2016; 11(12):e0167504. PubMed ID: 27936033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient classification and outcome prediction in IgA nephropathy.
    Diciolla M; Binetti G; Di Noia T; Pesce F; Schena FP; Vågane AM; Bjørneklett R; Suzuki H; Tomino Y; Naso D
    Comput Biol Med; 2015 Nov; 66():278-86. PubMed ID: 26453758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long range personalized cancer treatment strategies incorporating evolutionary dynamics.
    Yeang CH; Beckman RA
    Biol Direct; 2016 Oct; 11(1):56. PubMed ID: 27770811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five critical elements to ensure the precision medicine.
    Chen C; He M; Zhu Y; Shi L; Wang X
    Cancer Metastasis Rev; 2015 Jun; 34(2):313-8. PubMed ID: 25920354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opportunities and challenges in phenotypic drug discovery: an industry perspective.
    Moffat JG; Vincent F; Lee JA; Eder J; Prunotto M
    Nat Rev Drug Discov; 2017 Aug; 16(8):531-543. PubMed ID: 28685762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [From biomarkers to clinical decision support].
    Antal P; Reiter J; Mátyus P
    Orv Hetil; 2015 Dec; 156(51):2077-81. PubMed ID: 26654544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An approach to estimating product design time based on fuzzy v-support vector machine.
    Yan HS; Xu D
    IEEE Trans Neural Netw; 2007 May; 18(3):721-31. PubMed ID: 17526339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating clinical metabolomics-based biomarker discovery and clinical pharmacology to enable precision medicine.
    Kohler I; Hankemeier T; van der Graaf PH; Knibbe CAJ; van Hasselt JGC
    Eur J Pharm Sci; 2017 Nov; 109S():S15-S21. PubMed ID: 28502671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic influences on drug-induced psychomotor activation in mice.
    Gill KJ; Boyle AE
    Genes Brain Behav; 2008 Nov; 7(8):859-68. PubMed ID: 19076633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational modeling in melanoma for novel drug discovery.
    Pennisi M; Russo G; Di Salvatore V; Candido S; Libra M; Pappalardo F
    Expert Opin Drug Discov; 2016 Jun; 11(6):609-21. PubMed ID: 27046143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overview of the NCI precision medicine trials-NCI MATCH and MPACT.
    Do K; O'Sullivan Coyne G; Chen AP
    Chin Clin Oncol; 2015 Sep; 4(3):31. PubMed ID: 26408298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of partial classification algorithms using ROC curves.
    Tusch G
    Medinfo; 1995; 8 Pt 2():904-8. PubMed ID: 8591580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Logic models to predict continuous outputs based on binary inputs with an application to personalized cancer therapy.
    Knijnenburg TA; Klau GW; Iorio F; Garnett MJ; McDermott U; Shmulevich I; Wessels LF
    Sci Rep; 2016 Nov; 6():36812. PubMed ID: 27876821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials.
    Le Tourneau C; Kamal M; Tsimberidou AM; Bedard P; Pierron G; Callens C; Rouleau E; Vincent-Salomon A; Servant N; Alt M; Rouzier R; Paoletti X; Delattre O; Bièche I
    J Natl Cancer Inst; 2016 Apr; 108(4):. PubMed ID: 26598514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.